A new report published jointly by ECDC and WHO, shows a 24% drop in the rate of newly diagnosed HIV cases between 2019 and 2020. This drop is largely due to reduced HIV testing during 2020 as a result of COVID-19 restrictions and disruptions to services.
This report presents the results of the 10th round of the external quality assessment (EQA-10) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
In 2020, using data from countries able to provide at least two consecutive stages of the continuum, the overall performance of the European and Central Asian region against the global 90-90-90 targets is 82% of all PLHIV with HIV diagnosed, 67% of those diagnosed with HIV on treatment and 90% of those on treatment virally suppressed. More progress is needed to meet the substantive target of 73% of all PLHIV being virally suppressed, with performance for the overall region at 50% (based on the countries that submitted data for all four stages of the continuum).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 July 2021 and includes updates on Escherichia coli ST38, COVID-19, Vibrio growth in the Baltic Sea the Olympic Games in Tokyo 2020 (2021), West Nile virus, avian influenza and cholera.
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 July 2021 and includes updates on the Olympic games of Tokyo 2020, COVID-19, West Nile virus, measles, dengue, the UEFA European Football Championship 2020, and swine influenza.
The ECDC HIV Platform Tool is a new end-user application that uses statistical and mathematical methods to calculate adjusted estimates from HIV surveillance data, considering the issues of missing data and reporting delay and employing modelling techniques.
In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
Supplementary document with country case studies in relation to the ECDC operational guidance on HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: Implementation, standards and monitoring.